文献速递运动医学关节外科

距骨局灶性软骨缺损的手术治疗:贝叶斯网络荟萃分析

Surgical Management of Focal Chondral Defects of the Talus: A Bayesian Network Meta-analysis.
PubMed 文献 · Am J Sports Med · 2021-09-20

该贝叶斯网络荟萃分析比较了马赛克成形术、骨软骨自体与异体移植、微骨折、基质辅助自体软骨细胞移植及自体基质诱导成软骨(AMIC)治疗距骨软骨缺损的中期疗效。纳入13项研究共521例手术,随访中位数47.8个月,AMIC在AOFAS评分、VAS评分及失败率、翻修率上表现最佳。

要点

  • AMIC在距骨局灶性软骨缺损的中期随访中临床评分与并发症表现最优。
  • 共纳入13项研究521例手术,随访中位数47.8个月,证据等级为4级。
  • 各治疗组基线年龄、性别、BMI、AOFAS、VAS及缺损数量无差异。

核心结论

  • 在约4年随访时,AMIC治疗距骨局灶性软骨缺损的结局最佳。

研究设计与样本

  • 贝叶斯网络荟萃分析,证据等级4级,遵循PRISMA扩展声明。
  • 检索PubMed、Embase、Google Scholar和Scopus数据库至2021年2月。
  • 纳入比较2种及以上手术治疗距骨软骨缺损的临床试验,共13篇文章521例手术。

主要发现

  • 随访中位数47.8个月(范围31.7-66.8个月)。
  • 方差分析显示治疗组间基线年龄、性别、BMI、AOFAS评分、VAS评分及平均缺损数量无差异。
  • AMIC的AOFAS评分最高(SMD 11.27),VAS评分最低(SMD -2.26)。
  • AMIC的失败率(LOR 0.94)和翻修率(LOR 0.94)最低。
  • 总体不一致性检验无统计学意义。

关键数值与推荐

  • AMIC的AOFAS评分SMD为11.27,VAS评分SMD为-2.26。
  • AMIC的失败率LOR为0.94,翻修率LOR为0.94。

临床怎么用

  • 对于距骨局灶性软骨缺损,AMIC可作为优先考虑的手术方式之一。

局限性

  • 纳入研究证据等级为4级,整体证据质量有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: No consensus has been reached regarding the optimal surgical treatment for focal chondral defects of the talus. PURPOSE: A Bayesian network meta-analysis was conducted to compare the clinical scores and complications of mosaicplasty, osteochondral auto- and allograft transplant, microfracture, matrix-assisted autologous chondrocyte transplant, and autologous matrix-induced chondrogenesis (AMIC) for chondral defects of the talus at midterm follow-up. STUDY DESIGN: Bayesian network meta-analysis; Level of evidence, 4. METHODS: This Bayesian network meta-analysis followed the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions. PubMed, Embase, Google Scholar, and Scopus databases were accessed in February 2021. All clinical trials comparing 2 or more surgical interventions for the management of chondral defects of the talus were accessed. The outcomes of interest were visual analog scale (VAS) score, American Orthopaedic Foot and Ankle Society (AOFAS) score, rate of failure, and rate of revision surgery. The network meta-analysis were performed through the routine for Bayesian hierarchical random-effects model analysis. The log odds ratio (LOR) effect measure was used for dichotomous variables, and the standardized mean difference (SMD) was used for continuous variables. RESULTS: Data from 13 articles (521 procedures) were retrieved. The median length of the follow-up was 47.8 months (range, 31.7-66.8 months). Analysis of variance revealed no difference between the treatment groups at baseline in terms of age, sex, body mass index, AOFAS score, VAS score, and mean number of defects. AMIC demonstrated the greatest AOFAS score (SMD, 11.27) and lowest VAS score (SMD, -2.26) as well as the lowest rates of failure (LOR, 0.94) and revision (LOR, 0.94). The test for overall inconsistency was not significant. CONCLUSION: At approximately 4 years of follow-up, the AMIC procedure for management of focal chondral defects of the talus produced the best outcome.

来源:Am J Sports Med,查看原文。版权归原作者所有。

引用

  1. Migliorini F, Maffulli N, Schenker H, et al. Surgical Management of Focal Chondral Defects of the Talus: A Bayesian Network Meta-analysis. Am J Sports Med. 2021. PMID: 34543085. doi:10.1177/03635465211029642

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。